First-ever rapid-acting insulin. This approval extends to a 3-milliliter single-patient-use prefilled pen and a 10-milliliter ...
The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...
Insulin-aspart-szjj is the first rapid-acting insulin biosimilar approved and the third insulin product approved by the FDA.
The US Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart), ...
According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...
Thousands of U.S. health agency employees were terminated and told it was for poor performance, though they'd received strong ...
FDA approves third insulin biosimilar Merilog to ease U.S. supply shortage FDAs latest insulin biosimilar approval aims to mitigate ongoing supply challenges in the U.S.
Aventis’ rapid-acting insulin biosimilar product Merilog for improvement of glycaemic control in patients with diabetes: Maryland Monday, February 17, 202 ...
1d
Hosted on MSNBloomberg Industry Group Sues Non-Profit Drug Manufacturer for Producing Insulin at Lower CostsThe Bloomberg Industry Group has filed a legal action against a state agency challenging the transparency of an agreement to ...
Genetic engineering deployed to insert gene for human insulin into a bacterium, thus harnessing the substance for widespread ...
Mariposa California's original daily updated online newspaper is the premier site for news and information on Yosemite, ...
Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and pediatric patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results